P2Y12 inhibitors for acute coronary syndromes: current perspectives

P2Y12 inhibitors for acute coronary syndromes: current perspectives

James J Nawarskas,1 Cheyenne Newsome,2 Joe R Anderson,1 Bina Ahmed3 1Department of Pharmacy Practice and Pharmacy Administration, The University of New Mexico College of Pharmacy, 2Department of Pharmacy, The University of New Mexico Hospitals, 3Department of Internal Medicine, The University of New...

Full description

Bibliographic Details
Main Authors:	Nawarskas JJ, Newsome C, Anderson JR, Ahmed B
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-10-01
Series:	Research Reports in Clinical Cardiology
Online Access:	https://www.dovepress.com/p2y12-inhibitors-for-acute-coronary-syndromes-current-perspectives-peer-reviewed-article-RRCC

Similar Items

Critical appraisal of ticagrelor in the management of acute coronary syndrome
by: Nawarskas JJ, et al.
Published: (2011-12-01)

Anemia and acute coronary syndrome: current perspectives
by: Stucchi M, et al.
Published: (2018-05-01)

P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01)

Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome
by: Li-Man Luo, et al.
Published: (2020-11-01)

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
by: Charlotte Grosdidier, et al.
Published: (2019-10-01)

Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?
by: Raffaele De Caterina, et al.
Published: (2016-06-01)

Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?
by: Raffaele De Caterina, et al.
Published: (2016-06-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

Biomarkers in the prediction and management of acute coronary syndromes: current perspectives
by: Gilardi E, et al.
Published: (2014-01-01)

P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: A meta-analysis
by: Peng, F., et al.
Published: (2022)

THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01)

Erratum to “Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?”
by: Raffaele De Caterina, et al.
Published: (2016-11-01)

Erratum to “Do we need P2Y12 inhibitor pretreatment in non-ST elevation acute coronary syndrome?”
by: Raffaele De Caterina, et al.
Published: (2016-11-01)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
by: Patricia P. Wadowski, et al.
Published: (2019-07-01)

THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR
by: S. R. Gilyarevsky, et al.
Published: (2014-07-01)

P2Y12 Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model
by: James Gunton, et al.
Published: (2016-08-01)

Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
by: Maximilian Tscharre, et al.
Published: (2017-01-01)

Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy.
by: Ming-Yun Ho, et al.
Published: (2021-01-01)

Comparative efficacy and safety of oral P2Y 12 inhibitors after non-ST-elevation acute coronary syndromes: A network meta-analysis
by: Doundoulakis, I., et al.
Published: (2022)

Current management and hospital outcome of the acute coronary syndromes
by: I. Kanakakis, MD
Published: (2016-05-01)

Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?
by: Adriana Dana Oprea, et al.
Published: (2013-01-01)

Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018
by: Saurabh Gupta, et al.
Published: (2021-04-01)

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01)

Current Role of Computed Tomography in the Evaluation of Acute Coronary Syndrome
by: Min Ji Son, et al.
Published: (2021-02-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

ACUTE CORONARY SYNDROME IN ELDERLY: CURRENT STATUS AND UNRESOLVED ISSUES
by: О. N. Tkacheva, et al.
Published: (2017-06-01)

Acute coronary syndromes
by: Bergmark, B.A, et al.
Published: (2022)

Return to Work after an Acute Coronary Syndrome: Patients’ Perspective
by: Frans G. Slebus, et al.
Published: (2012-06-01)

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
by: Tingting Li, et al.
Published: (2021-01-01)

Association between Angiotensin-Converting Enzyme Inhibitors and Troponin in Acute Coronary Syndrome
by: Luiz Minuzzo, et al.
Published: (2014-12-01)

COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications
by: Matteo Cameli, et al.
Published: (2021-01-01)

To Be or Not to Be … Acute Coronary Syndrome
by: Irina Pintilie, et al.
Published: (2016-09-01)

Acute Coronary Syndromes
Published: (2012)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
by: Matthew A Silva, et al.
Published: (2006-03-01)

Asherman’s syndrome: current perspectives on diagnosis and management
by: Dreisler E, et al.
Published: (2019-03-01)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome.
by: Zhi-Jiang Xie, et al.
Published: (2021-01-01)

Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes
by: Hussam M Tayeb, et al.
Published: (2010-12-01)

NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES
by: G. S. Galjautdinov1, et al.
Published: (2018-07-01)

Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome
by: Rasha Kaddoura, et al.
Published: (2021-09-01)

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME
by: A. V. Rudakova, et al.
Published: (2015-09-01)